Ara
Toplam kayıt 1, listelenen: 1-1
Success of Eculizumab in the Treatment of Atypical Hemolytic Uremic Syndrome
(2015)
Disorders of complement regulation are the most important etiology of atypical hemolytic uremic syndrome (aHUS). Recent studies demonstrate that eculizumab is beneficial in long-term aHUS treatment. We present a series of ...